| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0001 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.001 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.002 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.081 | 0.003 |